In every issue of Hep, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Ryan Clary, executive director of the National Viral Hepatitis Roundtable, sits at the helm of U.S. efforts to end the epidemic.
Awareness and funding continue to be major challenges when it comes to viral hepatitis advocacy.
Nine countries are currently on track to eliminate HCV and HBV by 2030, but the United States is not among them.
The national increase in acute HCV infection is related to the country’s opioid epidemic and associated increases in injection drug use.
The city wants to reduce its number of opioid-related deaths.
Using TaSP to cure hepatitis C could help prevent new transmissions of the virus.
Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.
In a recent study, half of those cured of hepatitis C developed signs of non-alcoholic fatty liver disease (NAFLD).
Treating hepatitis C among those with cirrhosis reduces hospitalizations.
By modifying these barriers, clinicians hope to treat more hep C among patients undergoing opioid addiction treatment.